TARGETED MOLECULAR IMMUNOTHERAPY
Dead / Cancelled — Cancelled — Section 8 (as of 17 Feb 2023)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85363912
- Registration number
- 4185255
- Mark type
- Stylized text
- Filed
- 06 Jul 2011
- Published for opposition
- 22 May 2012
- Registered
- 07 Aug 2012
- Attorney of record
- Sabrina C. Stavish
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treatment of cancer and infectious disease; therapeutic and prophylactic vaccines
Owner
- Globeimmune, Inc., Louisville, CO, US
- Globeimmune, Inc., Louisville, CO, US
- Globeimmune, Inc., Louisville, CO, US
Prior registrations
Prosecution history
- 17 Feb 2023 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 07 Aug 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 16 Sept 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 16 Sept 2018 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 16 Sept 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Sept 2018 — TEAS SECTION 8 RECEIVED
- 07 Aug 2017 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 07 Aug 2012 — REGISTERED-PRINCIPAL REGISTER
- 22 May 2012 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 May 2012 — PUBLISHED FOR OPPOSITION
- 02 May 2012 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Apr 2012 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 12 Apr 2012 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Apr 2012 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Apr 2012 — CORRESPONDENCE RECEIVED IN LAW OFFICE